Lanean...
From bench to bedside: Therapeutic potential of interleukin-9 in the treatment of asthma
Initially identified as a T cell and mast cell growth factor, interleukin (IL)-9 has long been recognized as an important mediator of asthma. Recently, accumulating results from transgenic mice demonstrated that systemic or lung-specific overexpression of IL-9 caused asthma-associated symptoms. More...
Gorde:
Argitaratua izan da: | Exp Ther Med |
---|---|
Egile Nagusiak: | , , , , |
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
D.A. Spandidos
2017
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5347659/ https://ncbi.nlm.nih.gov/pubmed/28352305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.4024 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|